Grading of hemorrhage in children with idiopathic thrombocytopenic purpura

Journal of Pediatrics

Volumn 141, Issue 5, 2002, Pages 683-688

  Buchanan, George R ^a,b   Adix, Leah ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BLEEDING; CHILD; CORRELATION ANALYSIS; DISEASE SEVERITY; EPISTAXIS; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFANT; INSTRUMENTATION; MAJOR CLINICAL STUDY; MALE; MUCOSAL BLEEDING; ORAL BLEEDING; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; SKIN BLEEDING; THROMBOCYTE COUNT;

EID: 0036843499     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2002.128547     Document Type: Article

References (26)

1. Lilleyman JF. Management of childhood idiopathic thrombocytopenic purpura. Br J Haematol 1999;105:871-5.
2. Dickerhoff R, von Ruecker A. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment. J Pediatr 2000;137:629-32.
3. Blanchette V, Carcao M. Approach to the investigation and management of immune thrombocytopenic purpura in children. Semin Hematol 2000;37:299-314.
4. Vesely S, Buchanan GR, Cohen A, Raskob G, George J. Self-reported diagnostic and management strategies in childhood idiopathic thrombocytopenic purpura: Results of a survey of practicing pediatric hematology/oncology specialists. J Pediatr Hematol Oncol 2000;22:55-61.
5. Crosby WH. Wet purpura, dry purpura. JAMA 1975;232:744-5.
6. Bolton-Maggs PHB, Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet 1997;350:620-3.
7. Medeiros D, Buchanan GR. Major hemorrhage in children with idiopathic thrombocytopenic purpura: Immediate response to therapy and long-term outcome. J Pediatr 1998;133:334-9.
8. Blanchette VS, Luke B, Andrew M, Sommerville-Nielsen S, Barnard D, de Veber B, et al. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr 1993;123:989-95.
9. Buchanan GR, Adix L. Outcome measures and treatment endpoints other than platelet count in childhood idiopathic thrombocytopenic purpura. Semin Thromb Hemost 2001;27:277-85.
10. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40.
11. Bolton-Maggs PHB. Idiopathic thrombocytopenic purpura. Arch Dis Child 2000;83:220-2.
12. Hollander M, Wolfe DE. Nonparametric statistical methods. New York: John Wiley; 1999.
13. Cicchetti DV, Allison T. A new procedure for assessing reliability of scoring EEG sleep recordings. Am J EEG Therapy 1971;11:101-9.
14. Hartmann DP. Considerations in the choice of interobserver reliability estimates. J Appl Behav Analysis 1977;10:103-16.
15. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
16. George JN. Initial management of immune thrombocytopenic purpura in children: Is supportive counseling without therapeutic intervention sufficient? J Pediatr 2000;137:598-600.
17. Kühne T, Berchtold W, Van Be T, Van Binh T, Imbach P. Ethnicity and environment may affect the phenotype of immune thrombocytopenic purpura in children. Pediatr Res 2000;48:374-9.
18. Buchanan GR, Holtkamp CA. Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura. Am J Pediatr Hematol Oncol 1984;6:355-61.
19. Lacey JV, Penner JA. Management of idiopathic thrombocytopenic purpura in the adult. Semin Thromb Hemost 1977;3:160-74.
20. Katsanis E, Luke K-H, Hsu E, Li M, Lillicrap D. Prevalence and significance of mild bleeding disorders in children with recurrent epistaxis. J Pediatr 1988;113:73-6.
21. Dean JA, Blanchette VS, Carcao MD, Stain AM, Sparling CR, Siekmann J, et al. Von Willebrand disease in a pediatric-based population: Comparison of type 1 diagnostic criteria and use of the PFA-100 and a Von Willebrand factor/collagen-binding assay. Thromb Haemost 2000;84:401-9.
22. Nevo S, Enger C, Hartley E, Borinsky ME, Swan V, Fuller AK, et al. Acute bleeding and thrombocytopenia after bone marrow transplantation. Bone Marrow Transplant 2001;27:65-72.
23. Kitchens CS, Pendergast JF. Human thrombocytopenia is associated with structural abnormalities of the endothelium that are ameliorated by glucocorticosteroid administration. Blood 1986; 67:203-6.
24. Blajchman MA, Bordin JO, Bardossy L, Heddle NM. The contribution of the haematocrit to thrombocytopenic bleeding in experimental animals. Br J Haematol 1994;86:347-50.
25. Buchanan GR, Martin V, Levine PH, Scoon K, Handin RI. The effects of "anti-platelet" drugs on bleeding time and platelet aggregation in normal human subjects. Am J Clin Pathol 1977;68:355-9.
26. Modak SI, Bussel JB. Treatment of children with immune thrombocytopenic purpura: Are we closer to resolving the dilemma? J Pediatr 1998;133:313-4.